Drug intelligence / Profile preview

ViviGen

Development stage
Phase 4
Lead developer
LifeNet Health
Modality
Cell Therapies
Administration
Surgical Implantation
01

Overview

ViviGen is a cellular bone matrix (CBM) allograft developed by LifeNet Health and marketed by DePuy Synthes. It is a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) designed to support bone repair and fusion by providing three essential elements: an osteoconductive scaffold, osteoinductive signals, and osteogenic cells. Unlike many other cellular allografts that rely on mesenchymal stem cells (MSCs), ViviGen contains cryopreserved, lineage-committed bone cells (osteoblasts, osteocytes, and bone lining cells) that are already programmed to form bone. It is primarily utilized in spinal fusion procedures, such as Anterior Lumbar Interbody Fusion (ALIF) and Extreme Lateral Interbody Fusion (XLIF), and other orthopedic surgeries as an alternative to autograft or recombinant bone morphogenetic proteins.

Brand names
ViviGenViviGen Cellular Bone Matrix
Other names
ViviGen Cellular Bone MatrixCellular Bone MatrixCellular Allograft

Beyond the preview

Go deeper on ViviGen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViviGen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call